Patents by Inventor Cathy Ann-Rasmussen Ivarie

Cathy Ann-Rasmussen Ivarie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Skin substitutes with improved purity
    Patent number: 9295543
    Abstract: The present invention relates to in vitro cultured skin substitutes. In particular, the present invention relates to compositions and methods for the development of cultured skin substitutes using NIKS cells.
    Type: Grant
    Filed: March 15, 2006
    Date of Patent: March 29, 2016
    Assignee: STRATATECH CORPORATION
    Inventors: B. Lynn Allen-Hoffmann, Cathy Ann-Rasmussen Ivarie, John M. Centanni
  • Human skin equivalents expressing exogenous polypeptides
    Patent number: 9163076
    Abstract: The present invention relates generally to compositions for wound healing. More specifically, the present invention provides human skin equivalents engineered to express exogenous proteinase inhibitor polypeptides (e.g., TIMP-1 polypeptides) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: October 20, 2015
    Assignee: Stratatech Corporation
    Inventors: B. Lynn Allen-Hoffmann, Cathy Ann-Rasmussen Ivarie, Christina L. Thomas-Virnig
  • Skin substitutes and uses thereof
    Publication number: 20020164793
    Abstract: The present invention relates to in vitro cultured skin substitutes, and in particular to improved methods for organotypic culture of skin substitutes. In some embodiments, the dermal equivalent of the skin substitute is lifted to air interface of the culture prior to seeding with keratinocytes. In other embodiments, increased concentrations of collagen are used to form the dermal equivalent. In still other embodiments, optimized media are utilized to maintain the skin equivalents.
    Type: Application
    Filed: March 1, 2002
    Publication date: November 7, 2002
    Inventors: Paul Barth Conrad, Cathy Ann-Rasmussen Ivarie, Lynn Allen-Hoffmann